Literature DB >> 33945034

Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features.

Bruce I Gaynes1,2, Adnaan Zaffer3, Raman Yousefzai3, Mario Chazaro-Cortes3, Kalea Colletta3, Sandra L Kletzel3, Mary Beth Jost3, Youngsook Park3, Jasvinder Chawla3,4, Mark V Albert5, Ting Xiao6.   

Abstract

OBJECTIVES: Ascertain and quantify abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features based on a statistical predictive modeling strategy for PLR classification.
METHODS: Exploratory cohort analysis of pupillary kinetics in non-disease controls, PD subjects, and subjects with parkinsonism features using chromatic pupillometry. Receiver operating characteristic (ROC) curve interpretation of pupillary changes consistent with abnormality of intrinsically photosensitive retinal ganglion cells (ipRGCs) was employed using a thresholding algorithm to discriminate pupillary abnormality between study groups.
RESULTS: Twenty-eight subjects were enrolled, including 17 PD subjects (age range 64-85, mean 70.65) and nine controls (age range 48-95, mean 63.89). Two subjects were described as demonstrating parkinsonism symptoms due to presumed Lewy body dementia and motor system atrophy (MSA) respectively. On aggregate analysis, PD subjects demonstrated abnormal but variable pupillary dynamics suggestive of ipRGC abnormality. Subjects with parkinsonism features did not demonstrate pupillary changes consistent with ipRGC abnormality. There was no relationship between levodopa equivalent dosage or PD severity and ipRGC abnormality. The pupillary test sensitivity in predicting PD was 0.75 and likelihood ratio was 1.2.
CONCLUSIONS: ipRGC deficit is demonstrated in PD subjects; however, the degree and constancy of abnormality appear variable.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Blue light; Circadian; Parkinson’s disease; Retina

Mesh:

Substances:

Year:  2021        PMID: 33945034     DOI: 10.1007/s10072-021-05245-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

1.  Phototransduction by retinal ganglion cells that set the circadian clock.

Authors:  David M Berson; Felice A Dunn; Motoharu Takao
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice.

Authors:  R J Lucas; S Hattar; M Takao; D M Berson; R G Foster; K-W Yau
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

3.  Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy.

Authors:  N E Rosenthal; D A Sack; J C Gillin; A J Lewy; F K Goodwin; Y Davenport; P S Mueller; D A Newsome; T A Wehr
Journal:  Arch Gen Psychiatry       Date:  1984-01

4.  Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.

Authors:  Gregory L Willis; Adelheid M A Kelly; Gerard A Kennedy
Journal:  Behav Brain Res       Date:  2008-04-26       Impact factor: 3.332

5.  Intraocular microinjections repair experimental Parkinson's disease.

Authors:  Gregory L Willis
Journal:  Brain Res       Date:  2008-04-11       Impact factor: 3.252

6.  Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study.

Authors:  Gregory L Willis; E John D Turner
Journal:  Chronobiol Int       Date:  2007       Impact factor: 2.877

7.  Bright light therapy in Parkinson's disease: a pilot study.

Authors:  Sebastian Paus; Tanja Schmitz-Hübsch; Ullrich Wüllner; Antje Vogel; Thomas Klockgether; Michael Abele
Journal:  Mov Disord       Date:  2007-07-30       Impact factor: 10.338

Review 8.  Circadian rhythm sleep disorders in the blind and their treatment with melatonin.

Authors:  Debra J Skene; Josephine Arendt
Journal:  Sleep Med       Date:  2007-04-08       Impact factor: 3.492

9.  Bright light improves sleep in patients with Parkinson's disease: possible role of circadian restoration.

Authors:  Takuyuki Endo; Ritsuko Matsumura; Isao T Tokuda; Tomoko Yoshikawa; Yasufumi Shigeyoshi; Koichi Node; Saburo Sakoda; Makoto Akashi
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

10.  Defining the impact of melanopsin missense polymorphisms using in vivo functional rescue.

Authors:  Jessica Rodgers; Steven Hughes; Carina A Pothecary; Laurence A Brown; Doron G Hickey; Stuart N Peirson; Mark W Hankins
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.